How to Handle Polypharmacy in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC
Davide Stolfo(Azienda Sanitaria Universitaria Integrata di Trieste), Gianluigi Savarese(Karolinska Institutet), Basil S. Lewis(Technion – Israel Institute of Technology), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Pardeep S. Jhund(Copenhagen University Hospital), Maurizio Volterrani(Vita-Salute San Raffaele University), Sophie Van Linthout(Deutsches Herzzentrum der Charité), Antonio Cannatà(British Heart Foundation), Massimo Iacoviello(University of Foggia), Carlo G. Tocchetti(Federico II University Hospital), Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Frieder Braunschweig(Karolinska University Hospital), Giuseppe Rosano(St George's Hospital), Petar Seferović, Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Arsen Ristić(University of Belgrade), Sven Waßmann(Karolinska Institutet), Hadi Skouri(University of Balamand), Massimo Piepoli(University of Milan), Cristiana Vitale(St George's, University of London), Kalliopi Keramida(National and Kapodistrian University of Athens), Seif El Hadidi(University of Hertfordshire), Robin Ray(St George’s University Hospitals NHS Foundation Trust), Brenda Moura(Universidade do Porto), Maggie Simpson(Queen Elizabeth University Hospital), Marco Metra(Vita-Salute San Raffaele University), Markus S. Anker(Humboldt-Universität zu Berlin)
Cited by 36
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k